Stocks 619 records
| Ticker | Company | Sector | Price | Revenue Estimate | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
 | Vertex Pharmaceuticals Incorpor | Healthcare | $510.08 ≈ 455.25 € | 115.31B | 29.71 | 25.23 | 0.00% | -0.47% | +10.91% | +19.49% | FY Cur +10.45% (16) Q Cur +11.16% (13) FY Next +9.84% (16) Q Next +3.20% (14) | |
 | Moderna, Inc. | Healthcare | $225.00 ≈ 200.81 € | 80.17B | - | -50.7 | 0.00% | +0.26% | +547.81% | +605.59% | FY Cur +8.09% (21) Q Cur -12.17% (14) FY Next +16.07% (19) Q Next -24.31% (13) | |
 | Regeneron Pharmaceuticals, Inc. | Healthcare | $746.54 ≈ 666.29 € | 68.6B | 18.46 | 12.11 | 0.51% | -0.34% | -4.44% | +31.16% | FY Cur +20.31% (25) Q Cur +20.96% (19) FY Next +7.56% (23) Q Next +8.04% (18) | |
 | CSL FPO [CSL] | Healthcare | A$ 183.84 ≈ 114.62 € | 55.01B | - | 27.74 | 2.23% | +1.31% | +6.48% | -11.19% | FY Cur -0.26% (17) Q Cur - (0) FY Next +3.55% (17) Q Next - (0) | |
 | BEIGENE LTD | Healthcare | ¥249.42 ≈ 33.24 € | 49.15B | 83.14 | 45.69 | 0.00% | -0.45% | -8.3% | -18.08% | FY Cur +26.72% (31) Q Cur +24.34% (12) FY Next +14.92% (32) Q Next +1.74% (12) | |
 | argenx SE | Healthcare | $825.03 ≈ 736.34 € | 46.31B | 31.19 | 23.76 | 0.00% | -11.83% | -2.3% | +2.46% | FY Cur +48.20% (4) Q Cur +43.13% (2) FY Next +21.64% (4) Q Next +8.94% (2) | |
 | ARGENX SE | Healthcare | 728.40 € | 45.81B | 32.39 | 20.27 | 0.00% | -15.86% | -1.04% | +2.68% | FY Cur +48.20% (4) Q Cur +43.13% (2) FY Next +21.64% (4) Q Next +8.94% (2) | |
 | UCB | Healthcare | 203.50 € | 38.8B | 17.98 | 14.74 | 0.72% | -0.98% | -14.89% | -21.36% | FY Cur +11.86% (16) Q Cur - (0) FY Next +10.94% (16) Q Next - (0) | |
 | SAMSUNG BIOLOGICS | Healthcare | ₩1,219,000 ≈ 811.24 € | 37.77B | - | 25.22 | 0.00% | -4.54% | -28.08% | -21.81% | FY Cur -3.86% (20) Q Cur -18.32% (13) FY Next +16.23% (20) Q Next +13.32% (11) | |
 | Revolution Medicines, Inc. | Healthcare | $189.76 ≈ 169.36 € | 36.3B | - | -33.17 | 0.00% | -6.35% | +136.12% | +293.39% | FY Cur +0.00% (23) Q Cur +0.00% (20) FY Next +567.30% (23) Q Next +573.29% (19) | |
 | BeOne Medicines Ltd. | Healthcare | $354.47 ≈ 316.36 € | 35.99B | 63.41 | 34.58 | 0.00% | -3.82% | +14.9% | -0.27% | FY Cur +26.72% (31) Q Cur +24.34% (12) FY Next +14.92% (32) Q Next +1.74% (12) | |
 | BEONE MEDICINES | Healthcare | HK$ 209.60 ≈ 23.83 € | 35.25B | 63.32 | 239.81 | 0.00% | -1.6% | +14.79% | +4.28% | FY Cur +26.72% (31) Q Cur +24.34% (12) FY Next +14.92% (32) Q Next +1.74% (12) | |
 | BEONE MEDICINES | Healthcare | HK$ 209.60 ≈ 23.83 € | 35.25B | 63.32 | 239.81 | 0.00% | -1.6% | +14.79% | +4.28% | FY Cur +26.72% (31) Q Cur +24.34% (12) FY Next +14.92% (32) Q Next +1.74% (12) | |
 | Royalty Pharma plc | Healthcare | $56.93 ≈ 50.81 € | 29.36B | 30.28 | 9.82 | 1.67% | -0.97% | +44.17% | +56.05% | FY Cur +7.71% (5) Q Cur +8.70% (4) FY Next +8.97% (5) Q Next +6.38% (3) | |
 | Alnylam Pharmaceuticals, Inc. | Healthcare | $232.68 ≈ 207.67 € | 27.79B | 37.83 | 18.73 | 0.00% | +0.05% | -43.48% | -50.18% | FY Cur +47.50% (26) Q Cur +14.73% (20) FY Next +26.78% (26) Q Next +9.32% (20) | |
 | Celltrion | Healthcare | ₩179,600 ≈ 119.52 € | 27.25B | - | 23.49 | 0.40% | -2.13% | +4.19% | +7.27% | FY Cur +34.20% (20) Q Cur +41.60% (15) FY Next +13.92% (22) Q Next +9.69% (15) | |
 | WUXI BIO | Healthcare | HK$ 53.85 ≈ 6.12 € | 25.21B | 40.8 | 29.06 | 0.00% | -0.46% | +67.97% | +31.47% | FY Cur +17.96% (23) Q Cur - (0) FY Next +19.57% (25) Q Next - (0) | |
 | Roivant Sciences Ltd. | Healthcare | $35.44 ≈ 31.63 € | 22.85B | - | -20.63 | 0.00% | -1.55% | +58.16% | +113.41% | FY Cur +530.75% (12) Q Cur +136.10% (11) FY Next +685.92% (12) Q Next +231.50% (11) | |
 | BioNTech SE | Healthcare | $96.96 ≈ 86.54 € | 21.74B | - | -19.82 | 0.00% | -3.35% | -3.38% | -13.38% | FY Cur -37.73% (18) Q Cur -29.90% (11) FY Next +0.51% (17) Q Next -52.56% (11) | |
 | Incyte Corporation | Healthcare | $112.79 ≈ 100.67 € | 20.4B | 14.37 | 12.91 | 0.00% | -0.61% | +13.99% | +32.06% | FY Cur +15.49% (23) Q Cur +7.95% (20) FY Next +5.35% (23) Q Next +3.42% (19) | |
 | Genmab A/S | Healthcare | $37.07 ≈ 33.08 € | 20.34B | 29.19 | 24.31 | 0.00% | -1.64% | +14.48% | +10.11% | FY Cur +25.99% (19) Q Cur +20.30% (11) FY Next +16.94% (21) Q Next +5.32% (11) | |
 | Genmab A/S | Healthcare | 2,445.00 kr ≈ 326.82 € | 20.1B | 30.16 | 22.15 | 0.00% | -5.27% | +16.23% | +12.19% | FY Cur +25.99% (19) Q Cur +20.30% (11) FY Next +16.94% (21) Q Next +5.32% (11) | |
 | Insmed Incorporated | Healthcare | $100.60 ≈ 89.79 € | 19.61B | - | 127.76 | 0.00% | -1.24% | -42.28% | -37.9% | FY Cur +197.18% (22) Q Cur +250.76% (20) FY Next +59.72% (21) Q Next +12.87% (19) | |
 | INNOVENT BIO | Healthcare | HK$ 92.65 ≈ 10.54 € | 18.37B | 121.91 | 42.92 | 0.00% | +0.05% | +17.06% | -2.58% | FY Cur +42.30% (28) Q Cur - (0) FY Next +23.96% (30) Q Next - (0) | |
 | Ascendis Pharma A/S | Healthcare | $229.23 ≈ 204.59 € | 13.46B | 17.57 | 23.84 | 0.00% | -2.5% | +6.38% | +5.98% | FY Cur +90.14% (18) Q Cur +70.76% (16) FY Next +47.13% (18) Q Next +12.98% (16) | |
 | Exelixis, Inc. | Healthcare | $59.86 ≈ 53.43 € | 13.24B | 18.88 | 14.01 | 0.00% | +0.99% | +34.01% | +52.74% | FY Cur +10.09% (17) Q Cur +8.69% (15) FY Next +13.62% (16) Q Next +2.17% (15) | |
 | Jazz Pharmaceuticals plc | Healthcare | $218.42 ≈ 194.94 € | 12.65B | 14.97 | 8.46 | 0.00% | -3.78% | +30.22% | +61.45% | FY Cur +10.61% (21) Q Cur +6.94% (18) FY Next +5.76% (21) Q Next +2.65% (18) | |
 | Summit Therapeutics Inc. | Healthcare | $17.59 ≈ 15.70 € | 12.52B | - | -20.4 | 0.00% | -4.35% | -1.83% | -26.44% | FY Cur +0.00% (15) Q Cur +0.00% (14) FY Next +1326.97% (15) Q Next +5415.31% (14) | |
 | SKB BIO | Healthcare | HK$ 444.60 ≈ 50.56 € | 12.08B | 617.5 | 127.64 | 0.00% | -0.27% | +11.37% | -12.91% | FY Cur +23.57% (20) Q Cur - (0) FY Next +73.92% (20) Q Next - (0) | |
 | Corcept Therapeutics Incorporat | Healthcare | $121.19 ≈ 108.16 € | 11.69B | 269.31 | 27.53 | 0.00% | -0.89% | +68.86% | +34.05% | FY Cur +50.53% (4) Q Cur +62.00% (4) FY Next +48.75% (4) Q Next +15.57% (4) | |
 | AKESO | Healthcare | HK$ 109.10 ≈ 12.41 € | 11.43B | - | 83.53 | 0.00% | +3.22% | -1.98% | -17.03% | FY Cur +51.67% (21) Q Cur - (0) FY Next +51.60% (21) Q Next - (0) | |
 | BridgeBio Pharma, Inc. | Healthcare | $65.35 ≈ 58.32 € | 11.4B | - | 2.26K | 0.00% | -2.2% | -13.83% | +17.61% | FY Cur +104.49% (19) Q Cur +124.02% (17) FY Next +65.30% (18) Q Next +17.06% (17) | |
 | Halozyme Therapeutics, Inc. | Healthcare | $110.42 ≈ 98.55 € | 11.19B | 32.29 | 10.39 | 0.00% | -0.86% | +62.25% | +68.47% | FY Cur +33.93% (8) Q Cur +38.31% (6) FY Next +10.74% (8) Q Next +10.76% (6) | |
 | Alteogen | Healthcare | ₩241,000 ≈ 160.39 € | 11.17B | - | 44.61 | 0.12% | -6.23% | -30.3% | -33.55% | FY Cur +125.92% (6) Q Cur +151.79% (3) FY Next +35.36% (6) Q Next +74.31% (3) | |
 | GENSCRIPT BIO | Healthcare | HK$ 42.40 ≈ 4.82 € | 10.99B | - | 588.89 | 0.00% | +4.18% | +240.56% | +148.24% | FY Cur -7.31% (6) Q Cur - (0) FY Next +20.79% (7) Q Next - (0) | |
 | SBP GROUP | Healthcare | HK$ 5.41 ≈ 0.62 € | 10.96B | 36.07 | 20.11 | 2.55% | -1.37% | -13.85% | -31.52% | FY Cur +14.23% (22) Q Cur - (0) FY Next +6.11% (23) Q Next - (0) | |
 | PHARMARON | Healthcare | ¥43.11 ≈ 5.74 € | 10.55B | 45.38 | 30.47 | 0.46% | -1.46% | +49.74% | +22.12% | FY Cur +18.55% (10) Q Cur +19.53% (1) FY Next +17.92% (11) Q Next +10.71% (1) | |
 | Bio-Techne Corp | Healthcare | $72.46 ≈ 64.67 € | 10.14B | 62.47 | 31.33 | 0.44% | -0.11% | +22.55% | +19.63% | FY Cur +4.35% (12) Q Cur +1.97% (8) FY Next +10.04% (9) Q Next +5.33% (7) | |
 | ImmunityBio, Inc. | Healthcare | $10.51 ≈ 9.38 € | 9.94B | - | -75.07 | 0.00% | +1.64% | +400.51% | +291.7% | FY Cur +99.26% (4) Q Cur +84.73% (4) FY Next +101.32% (4) Q Next +20.24% (4) | |
 | Madrigal Pharmaceuticals, Inc. | Healthcare | $471.75 ≈ 421.04 € | 9.73B | - | 49.01 | 0.00% | -2.22% | -18.3% | +9.15% | FY Cur +59.37% (18) Q Cur +41.14% (17) FY Next +39.35% (17) Q Next +9.89% (17) | |
 | Vaxcyte, Inc. | Healthcare | $71.38 ≈ 63.71 € | 9.48B | - | -9.92 | 0.00% | -2.9% | +43.17% | +59.59% | FY Cur +0.00% (9) Q Cur +0.00% (9) FY Next - (9) Q Next - (9) | |
 | BioMarin Pharmaceutical Inc. | Healthcare | $54.80 ≈ 48.90 € | 9.47B | 148.09 | 8.26 | 0.00% | -0.56% | -6.95% | +0.37% | FY Cur +21.29% (24) Q Cur +32.03% (20) FY Next +14.48% (24) Q Next +9.79% (20) | |
 | Twist Bioscience Corporation | Healthcare | $159.78 ≈ 142.60 € | 9.45B | - | -399.45 | 0.00% | -2.31% | +372.94% | +363.71% | FY Cur +21.18% (12) Q Cur +24.77% (11) FY Next +20.16% (11) Q Next +2.34% (8) | |
 | HAISCO PHARMA | Healthcare | ¥61.02 ≈ 8.13 € | 9.28B | 68.56 | - | 1.33% | +2.71% | +20.55% | +15.28% | FY Cur +60.34% (2) Q Cur - (1) FY Next -2.51% (4) Q Next +4.08% (1) | |
 | Apogee Therapeutics, Inc. | Healthcare | $135.07 ≈ 120.55 € | 9.12B | - | -26 | - | 0% | - | - | FY Cur +0.00% (6) Q Cur +0.00% (6) FY Next - (7) Q Next - (6) | |
 | Krystal Biotech, Inc. | Healthcare | $331.61 ≈ 295.96 € | 8.76B | 41.56 | 35.78 | 0.00% | +0.84% | +32.04% | +74.86% | FY Cur +29.71% (9) Q Cur +31.99% (9) FY Next +28.43% (10) Q Next +7.22% (9) | |
 | Nuvalent, Inc. | Healthcare | $123.96 ≈ 110.63 € | 8.74B | - | -30.85 | - | 0% | - | - | FY Cur +0.00% (10) Q Cur +0.00% (9) FY Next +1586.09% (10) Q Next - (9) | |
 | ASYMCHEM | Healthcare | ¥177.93 ≈ 23.71 € | 8.58B | 60.73 | 34.84 | 0.72% | -1.52% | +91.32% | +56.79% | FY Cur +21.26% (12) Q Cur +44.30% (1) FY Next +21.20% (12) Q Next +10.30% (1) | |
 | Kymera Therapeutics, Inc. | Healthcare | $112.40 ≈ 100.32 € | 8.34B | - | -22.1 | 0.00% | +0.88% | +39.91% | +94.17% | FY Cur +167.23% (23) Q Cur +12.27% (19) FY Next -61.21% (22) Q Next +12.80% (19) | |
 | Protagonist Therapeutics, Inc. | Healthcare | $143.73 ≈ 128.28 € | 8.3B | 139.54 | -721.72 | 0.00% | -0.72% | +60.34% | +114.26% | FY Cur +92.30% (12) Q Cur +5064.80% (11) FY Next -62.49% (12) Q Next -85.10% (9) |
Rows per page:
Page 1 of 13
Results: 619
USMkt Cap
115.31B
P/E 29.71
+19.49% 1Y
USMkt Cap
11.69B
P/E 269.31
+34.05% 1Y
Results 1 - 50 of 619
Per page:
Page 1 / 13